Studies related to Symptoms of Oral Cancer and Spirulina

Evaluation Of Chemoprevention Of Oral Cancer With Spirulina Fusiformis

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 87
Sex Both Genders
Age Range 18-29, 30-44, 45-64, 65+
Body Types Average
Notes for this study:
Spirulina, at 1g daily for a year, was associated with resolution of lesions in 20/45 persons using Spirulina and 7% of persons in placebo; tobacco users.